Adam Waalkes
- Molecular Biology
- Infectious Diseases top 10%
- Molecular Medicine top 5%
- Clinical Biochemistry top 5%
- Genetics
- Co-authors
- Stephen J. SalipanteKelsi PenewitElizabeth A. HolmesBrian J. WerthLibin XuKelly M. HinesKathryn McLeanDustin R. Long
- Topics
- Antimicrobial Resistance in Staphylococcus (14 papers)Bacterial biofilms and quorum sensing (11 papers)Antibiotic Resistance in Bacteria (10 papers)
- Journals
- American Journal of Respiratory and Critical Care MedicineClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Adam Waalkes
36 papers receiving 750 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 379
- Infectious Diseases 239
- Molecular Medicine 161
- Clinical Biochemistry 95
- Genetics 90
Countries citing papers authored by Adam Waalkes
This map shows the geographic impact of Adam Waalkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Waalkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Waalkes more than expected).
Fields of papers citing papers by Adam Waalkes
This network shows the impact of papers produced by Adam Waalkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Waalkes. The network helps show where Adam Waalkes may publish in the future.
Co-authorship network of co-authors of Adam Waalkes
This figure shows the co-authorship network connecting the top 25 collaborators of Adam Waalkes. A scholar is included among the top collaborators of Adam Waalkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Waalkes. Adam Waalkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 17 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 4 | |
| 9 | 7 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 31 | |
| 13 | 32 | |
| 14 | 4 | |
| 15 | 6 | |
| 16 | 33 | |
| 17 | 16 | |
| 18 | 53 | |
| 19 | 21 | |
| 20 | 71 |
About Adam Waalkes
Adam Waalkes is a scholar working on Molecular Medicine, Infectious Diseases and Clinical Biochemistry, having authored 38 papers that have together received 759 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (14 papers), Bacterial biofilms and quorum sensing (11 papers) and Antibiotic Resistance in Bacteria (10 papers). The work is most often cited by research in Molecular Medicine (161 citations), Clinical Biochemistry (95 citations) and Endocrinology (71 citations). Adam Waalkes has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Stephen J. Salipante, Kelsi Penewit, Elizabeth A. Holmes, Brian J. Werth, Libin Xu, Kelly M. Hines, Kathryn McLean, Dustin R. Long, Ronald J. Hause and Tianwei Shen. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.